Monte Rosa Therapeutics develops small molecule drugs that break down proteins tied to immune disorders and cancers. It last closed at $8.64 on Nov 20, down 3.03% on the day. The next earnings report for GLUE is expected around Tue, Mar 16, 2027. Over its last 8 reports the stock moved an average of 4.3% the session after earnings. Over the last 12 months GLUE insiders bought $0 of stock on the open market and sold $4.1M, according to SEC Form 4 filings.
AI Auto Pilots
Is GLUE in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold GLUE.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on GLUEStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
GLUE · as of the Nov 20 close · updated each morning
Downtrend, oversold
The stock is 16% below its 20 day and 25% below its 50 day average. It is 91% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 27), oversold. The nearest support is the 52 week low at $8.48, and the nearest resistance the Pivot at $8.72.
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityNormal, 6.8%/day
Key levels
$25.7752 week high+198.3%
$16.46200 day average+90.5%
$14.52100 day average+68.1%
$11.20Swing high (Oct 29)+29.6%
$10.7850 day average+24.8%
$10.0620 day average+16.4%
$8.96Pivot R1+3.7%
$8.72Pivot+0.9%
$8.64Last close
$8.4852 week low−1.9%
$8.40Pivot S1−2.8%
Indicators
RSI (14)
27.24
Oversold below 30
Oversold
MACD
-0.60
Below its signal line
Bearish
Stochastic
7.8
Near the bottom of its range
Oversold
ADX (14)
31.7
Trending down
Williams %R
-93.8
Oversold below −80, overbought above −20
Oversold
CCI (20)
-137.2
Oversold below −100, overbought above 100
Oversold
Rate of change
−18.3%
Change over 10 sessions
Bearish
ATR (14)
$0.59
Typical daily range, 6.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Pullback inside a longer uptrend, nearing oversold
Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityNormal, 22.9%/day
Key levels
$25.7752 week high+198.3%
$16.46200 day average+90.5%
$14.52100 day average+68.1%
$11.20Swing high (Oct 29)+29.6%
$10.7850 day average+24.8%
$10.0620 day average+16.4%
$8.96Pivot R1+3.7%
$8.72Pivot+0.9%
$8.64Last close
$8.4852 week low−1.9%
$8.40Pivot S1−2.8%
Indicators
RSI (14)
31.47
Weak, oversold below 30
Neutral
MACD
-2.24
Below its signal line
Bearish
Stochastic
6.6
Near the bottom of its range
Oversold
ADX (14)
30.5
Trending down
Williams %R
-97.9
Oversold below −80, overbought above −20
Oversold
CCI (20)
-99.2
Oversold below −100, overbought above 100
Neutral
Rate of change
−38.6%
Change over 10 sessions
Bearish
ATR (14)
$1.98
Typical daily range, 22.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for GLUE
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how GLUE did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow GLUE usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for GLUEHow many large options trades hit GLUE, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in GLUE in the last 90 days.
From SEC Form 4 filings by GLUE's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether GLUE is in one of them and how their past GLUE trades turned out.
Monte Rosa Therapeutics is a biotechnology company based in Boston, Massachusetts. It develops small molecule drugs called molecular glue degraders, which use the body's natural protein disposal system to break down proteins tied to disease. Its candidates are in clinical trials for immune conditions, inflammatory diseases, and prostate cancer, and it is developing programs for other cancers. Its main partner is Novartis, which has licensed one of its immune disease programs.